本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2016/2/181 分钟阅读
Effective Date of Requirement for Premarket Approval for Total Metal-on-Metal Semi-Constrained Hip Joint Systems
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) is issuing a final order to require the filing of a premarket approval application (PMA) or a notice of completion of a product development protocol (PDP) for the hip joint metal/metal semi-constrained, with a cemented acetabular component, prosthesis; and hip joint metal/metal semi-constrained, with an uncemented acetabular component, prosthesis.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →